The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections

Show other versions (1)

Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARSCov- 2 pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID- 19 infection, while advances in immunological profiling are guiding clinical treatment. The SARSCov- 2 virus has undergo...

Full description

Saved in:

Bibliographic Details
Main Author:	Keneth Iceland, Kasozi
Format:	Article
Published:	MDPI 2021
Subjects:	COVID-19 therapy; COVID-19 vaccine; COVID-19 convalescent therapy; SARS-CoV-2 infection; human antibodies; variants of concern; Ebola
Online Access:	http://hdl.handle.net/20.500.12493/532
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed, Moubarak, et al.
Published: (2023)

Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection
by: Parastoo Hosseini, et al.
Published: (2021-03-01)

Neutralizing antibodies from naturally infected individuals against SARS-CoV-2 Gamma and Delta variants in the Paraguayan population
by: Angélica Samudio, et al.
Published: (2023-10-01)

Clinical efficacy and safety of convalescent plasma therapy for patients with SARS-CoV-2 infection
by: D. V. Lavrenchuk, et al.
Published: (2022-04-01)

Neutralization Activity of Standard and Hyperimmune Intravenous Immunoglobulins Against Recently Circulating SARS-CoV-2 Variants
by: Dongxiao Liu, et al.
Published: (2025-07-01)

Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination
by: Miao Wang, et al.
Published: (2023-12-01)

Efficacy of COVID convalescent plasma therapy in hospitalized moderate coronavirus disease 2019 patients
by: Cosphiadi Irawan, et al.
Published: (2023-01-01)

Convalescent plasma therapy for COVID-19 – Donor selection strategies and establishment of a plasma bank
by: Mikael Kajova, et al.
Published: (2024-12-01)

Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report
by: Mira Yulianti, et al.
Published: (2022-01-01)

HISTORY OF PLASMA THERAPY: A CURRENTLY USED TREATMENT OPTION FOR COVID-19
by: Esra Bilir, et al.
Published: (2021-07-01)

SARS-CoV-2 Mutations and Their Impacts on Virulence and Transmissibility of The Virus
by: Sajjad Bahman, et al.
Published: (2024-07-01)

RADx Variant Task Force Program for Assessing the Impact of Variants on SARS-CoV-2 Molecular and Antigen Tests
by: Richard Creager, et al.
Published: (2021-01-01)

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trialResearch in context
by: Simone Hoffmann, et al.
Published: (2025-03-01)

Experimental co-infection of calves with SARS-CoV-2 Delta and Omicron variants of concern
by: Konner Cool, et al.
Published: (2024-12-01)

Cytokine profile of COVID-19 convalescent plasma and its relationship to outcome of treated patients
by: Michael P. Potapnev, et al.
Published: (2025-04-01)

On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
by: Katarzyna Jabłońska, et al.
Published: (2021-01-01)

Features of the myocardial infarction course in convalescents of the new coronavirus infection COVID-19
by: N. A. Muradyan, et al.
Published: (2023-09-01)

What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?
by: Sanda Ravlić, et al.
Published: (2023-12-01)

Neutralizing antibody responses to SARS-CoV-2 variants after COVID-19 vaccination and boosters
by: Kabita Adhikari, et al.
Published: (2025-06-01)

A practical approach for the compassionate use of convalescent plasma in patients with severe COVID-19 in developing countries
by: Brenner Elías Sabando Vélez, et al.
Published: (2020-07-01)

COMPARISON OF MORTALITY BETWEEN THE COMBINATION OF STANDARD THERAPY AND CONVALESCENT PLASMA THERAPY AND STANDARD THERAPY ONLY IN COVID-19 PATIENTS : SYSTEMATIC REVIEW AND META-ANALYSIS
by: Felicia Klarin, et al.
Published: (2021-10-01)

Association Between COVID-19 and ABO Blood Groups: An Analysis on Convalescent Plasma Donors in Turkey
by: Mustafa Yilmaz, et al.
Published: (2021-06-01)

Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
by: Jared Sheehan, et al.
Published: (2025-01-01)

A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern
by: I-Jung Lee, et al.
Published: (2023-12-01)

Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial
by: Benoît Misset, et al.
Published: (2024-10-01)

Severity of Postcovid Syndrome in Convalescent Covid-19 and Their Association with the Main Risk Factors for Chronic Non-Communicable Diseases
by: A. A. Karaseva, et al.
Published: (2024-08-01)

Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants
by: Frédéric Coutant, et al.
Published: (2024-12-01)

T‐Cell‐Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS‐CoV‐2 Infection
by: Wenyan Fu, et al.
Published: (2025-04-01)

Confirmed Delta Variant COVID-19 Infection at A Single Centre Tertiary Hospital: A Case Series
by: Sally Aman Nasution, et al.
Published: (2022-07-01)

Sustained expression of inflammatory monocytes and activated T cells in COVID‐19 patients and recovered convalescent plasma donors
by: Ravinder Singh, et al.
Published: (2021-12-01)

Remdesivir and hospitalization outcomes in patients with COVID -19 in the period of SARS-CoV-2 Delta circulation
by: D. V. Litvinchuk, et al.
Published: (2025-06-01)

SARS-CoV-2 genetic diversity and variants of concern in Saudi Arabia
by: Dalia Abdullah Obeid, et al.
Published: (2021-12-01)

Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody
by: Tingting Li, et al.
Published: (2021-11-01)

The Clinical Anatomy of SARS-CoV-2 Variants of Concern in Central Greece During October 2020–July 2022
by: Ioanna Voulgaridi, et al.
Published: (2024-12-01)

Evaluating convalescent plasma therapy in severe COVID-19: a retrospective cohort study
by: Masoud Moeini Taba, et al.
Published: (2024-12-01)

Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population
by: Zhigang Yi, et al.
Published: (2020-01-01)

Spatiotemporal prevalence of COVID-19 and SARS-CoV-2 variants in Africa
by: Li-Ping Gao, et al.
Published: (2025-02-01)

Epidemiology of reinfections by SARS-CoV-2 variants during the third and fourth waves of the COVID-19 pandemic
by: Eduardo García-Moncada, et al.
Published: (2024-09-01)

Real-time estimates of the emergence and dynamics of SARS-CoV-2 variants of concern: A modeling approach
by: Nicolò Gozzi, et al.
Published: (2024-12-01)

Plasma cytokines in patients with COVID-19 during acute phase of the disease and following complete recovery
by: N. A. Arsentieva, et al.
Published: (2021-05-01)